Cognition Therapeutics Inc (CGTX)

NASDAQ HEALTHCARE

$1.45 +2.11% RSI 65 Neutral Add Alert

Moving Averages

SMA 200

$1.41

Price near

Company Profile

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company is headquartered in Purchase, New York.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$107.40M

P/E Ratio

None

EPS

$-0.23

Beta

1.751